Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,492,920
  • Shares Outstanding, K 138,321
  • Annual Sales, $ 1,697 M
  • Annual Income, $ -190,430 K
  • EBIT $ -352 M
  • EBITDA $ -321 M
  • 60-Month Beta 1.64
  • Price/Sales 14.52
  • Price/Cash Flow N/A
  • Price/Book 25.33

Options Overview Details

View History
  • Implied Volatility 50.73% (+3.65%)
  • Historical Volatility 43.67%
  • IV Percentile 57%
  • IV Rank 33.38%
  • IV High 86.29% on 04/08/25
  • IV Low 32.92% on 06/16/25
  • Expected Move (DTE 16) 41.22 (19.86%)
  • Put/Call Vol Ratio 0.77
  • Today's Volume 843
  • Volume Avg (30-Day) 643
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 10,921
  • Open Int (30-Day) 11,036
  • Expected Range 166.27 to 248.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.46
  • Number of Estimates 5
  • High Estimate -0.28
  • Low Estimate -0.68
  • Prior Year -0.41
  • Growth Rate Est. (year over year) -12.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
205.00 +0.18%
on 02/04/26
256.36 -19.89%
on 01/07/26
-23.48 (-10.26%)
since 01/02/26
3-Month
182.20 +12.71%
on 11/07/25
256.36 -19.89%
on 01/07/26
+8.91 (+4.54%)
since 11/04/25
52-Week
125.38 +63.79%
on 04/07/25
256.36 -19.89%
on 01/07/26
+31.12 (+17.86%)
since 02/04/25

Most Recent Stories

More News
Natera Submits Signateraâ„¢ CDx PMA to FDA

Application backed by landmark phase 3 data validating MRD-guided treatment in bladder cancer

NTRA : 205.80 (-9.61%)
Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation

ACES-EMB is the first randomized-controlled trial to compare dd-cfDNA surveillance to routine biopsy in organ transplantation, highlighting the benefits of Prosperaâ„¢ in organ rejection

NTRA : 205.80 (-9.61%)
Prosperaâ„¢ Featured in Landmark Interventional Study Advancing Lung Transplant Care

New publication shows that Prospera-guided care helped >75% of low-risk patients safely avoid routine transbronchial biopsies performed at 9 months

NTRA : 205.80 (-9.61%)
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

NTRA : 205.80 (-9.61%)
SYK : 365.25 (+1.23%)
SUPN : 48.96 (+1.16%)
Natera Publishes Clinical Validation of Latitudeâ„¢ Tissue-Free MRD Test in Colorectal Cancer

Study reports high sensitivity and specificity, enabling MolDX submission and path to reimbursement in CRC

NTRA : 205.80 (-9.61%)
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting

EXPAND clinical trial to be presented; data support Fetal Focusâ„¢ sgNIPT for inherited conditions

NTRA : 205.80 (-9.61%)
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling

New AI-derived model integrates longitudinal ctDNA and clinical data with digital pathology and tumor sequencing data, to refine recurrence risk assessment and outcomes prediction

NTRA : 205.80 (-9.61%)
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA

Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the development of Natera’s multimodal...

NTRA : 205.80 (-9.61%)
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signateraâ„¢ Growth

2025 revenues are expected to increase by approximately 35% compared to 2024, which is approximately $40 million above the top end of Natera’s financial outlook Additional...

NTRA : 205.80 (-9.61%)
2 Cash-Heavy Stocks to Keep an Eye On and 1 We Question

2 Cash-Heavy Stocks to Keep an Eye On and 1 We Question

MCFT : 23.13 (+3.96%)
NTRA : 205.80 (-9.61%)
CPNG : 19.15 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 247.14
2nd Resistance Point 241.86
1st Resistance Point 234.77
Last Price 205.80
1st Support Level 222.40
2nd Support Level 217.12
3rd Support Level 210.03

See More

52-Week High 256.36
Fibonacci 61.8% 206.33
Last Price 205.80
Fibonacci 50% 190.87
Fibonacci 38.2% 175.41
52-Week Low 125.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar